| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/05/2007 | WO2007037438A1 Ameliorating agent for metabolic syndrome |
| 04/05/2007 | WO2007037430A1 T-cell adhesion molecule and antibody directed against the molecule |
| 04/05/2007 | WO2007037425A1 Anti-diabetic composition |
| 04/05/2007 | WO2007037423A1 Antidiabetic agent |
| 04/05/2007 | WO2007037413A1 Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level |
| 04/05/2007 | WO2007037333A1 Inhibitor of binding to non-typical proline-rich sequence |
| 04/05/2007 | WO2007037296A1 Medical agent containing insulin resistance improving agent |
| 04/05/2007 | WO2007037295A1 Wrinkling prevention or mitigation with adam inhibitor |
| 04/05/2007 | WO2007037258A1 Therapeutic agent for attention deficit/hyperactivity disorder |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007037133A1 Method for evaluation of compound capable of acting on plk3 |
| 04/05/2007 | WO2007037060A1 Composition for acceleration of type i collagen production |
| 04/05/2007 | WO2007036743A2 Quinolines and their therapeutic use |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078260 Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them |
| 04/05/2007 | US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078080 N4-Acylcytosine Nucleosides for Treatment of Viral Infections |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | DE102005033902B3 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them |
| 04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | CA2624135A1 T-cell adhesion molecule and antibody thereto |
| 04/05/2007 | CA2623958A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | CA2622000A1 Quinolines and their therapeutic use |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1770162A1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770159A1 Process for manufacturing a pharmaceutical composition for treating diabetes |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769799A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 04/04/2007 | EP1769795A2 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/04/2007 | EP1768665A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 04/04/2007 | EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/04/2007 | EP1541673B1 Probiotics for pet food applications |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1401422B1 Halogenated composition, method for preparing same and uses thereof |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1383447A4 Stent-based delivery of statins to prevent restenosis |
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1332139B1 Anticancer agents based on regulation of protein prenylation |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1307205B1 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/04/2007 | EP1294385B1 Method for the production of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross-linking in the presence of chemically non-reacting effectors of the oxygen affinity of the haemoglobin |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1239861B1 Combination of cyamemazine and an atypical neuroleptic |
| 04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | EP0969835B1 Use of central cannabinoid receptor antagonists for regulating appetency |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942184A Niosame having metal porphyrin complex embedded therein, process for it and drug with use thereof |
| 04/04/2007 | CN1939930A Low-molecular TPO agonist antibodies |
| 04/04/2007 | CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1939537A Production of gamma immune protein capsules |
| 04/04/2007 | CN1939529A Compositions and methods for modulating connexin hemichannels |
| 04/04/2007 | CN1939513A Chinese-medicinal composition for treating swine asitia, thin and growth lag |
| 04/04/2007 | CN1939488A Externally-applied ointment for treating subcutaneous abscess and its preparation |
| 04/04/2007 | CN1939453A Gambir plant extract and its use in preparation of target organ protective medicine |
| 04/04/2007 | CN1939401A Animal medicament with liverfire-clearing and digesting functions and its making method |
| 04/04/2007 | CN1939384A Medicated liquor for treating malnutrition with accumulation |
| 04/04/2007 | CN1939376A Chinese-medicinal composition, its preparation and use |
| 04/04/2007 | CN1939365A Cell-repairing oral liquid |
| 04/04/2007 | CN1939358A Sarcandra glaber dispersant tablets |
| 04/04/2007 | CN1939339A Chinese-medicinal composition for treating fowl and animal thermal stress |
| 04/04/2007 | CN1939332A Medical usage of S-adenyhomotype cysteine |
| 04/04/2007 | CN1939307A 2,4,6-triamino-1,3,5-triazine derivative |
| 04/04/2007 | CN1939301A Slow-releasing preparation containing Vitamin E niacin ester and its making method |
| 04/04/2007 | CN1939299A Combinations comprising epothilone derivatives and alkylating agents |
| 04/04/2007 | CN1939279A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308447C Degraded agonist antibody |
| 04/04/2007 | CN1308442C Method for purifying enzyme, purified enzyme produced thereby and use of this enzyme |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308327C Imidazopyridine derivatives |
| 04/04/2007 | CN1308325C Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 04/04/2007 | CN1308324C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308317C New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/04/2007 | CN1308038C Novel combination of glucocorticoids and PDG-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD |
| 04/04/2007 | CN1308029C Application of Chinese ginger extract in preparation of fatty acid synthetase inhibitor |
| 04/04/2007 | CN1308007C Cerebrum nourishment intensification prescription |
| 04/04/2007 | CN1307998C Novel method and compositions for local treatment of Meniere's disease, tinnitus and hearing loss |
| 04/04/2007 | CN1307990C Triglyceride depressant composition |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199239 Chemical compounds |